Preclinical Models of CMML (TET2/NRAS) & Sensitivity to MAPK Inhibitor - A Shih
MDS Foundation, Inc.
0:00 / 0:00
Preclinical Models of CMML (TET2/NRAS) & Sensitivity to MAPK Inhibitor - A Shih
357 просмотров · 5 л. назад
MDS Foundation, Inc.
1,2 тыс. подписчиков
357 просмотров · 5 л. назад
Description
